Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant vs Mirtazapine for PONV in LSG
NCT04013386Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant, mirtazapine in postoperative nausea and vomiting (PONV), sponsored by Ain Shams University. Started Jul 2019; status: completed.
02
Drugs
aprepitantmirtazapine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04013386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013386.